Cargando…

Beta-blockers in septic shock: What is new?

The use of beta(β)-blockers during septic shock aimed at countering peripheral adrenergic stress may be justified by the early reduction in deleterious effects resulting from sympathetic overactivation, and could improve the prognosis of patients in septic shock. Animal studies have demonstrated eit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lescroart, Mickael, Pequignot, Benjamin, Kimmoun, Antoine, Klein, Thomas, Levy, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923987/ https://www.ncbi.nlm.nih.gov/pubmed/36789018 http://dx.doi.org/10.1016/j.jointm.2022.01.004

Ejemplares similares

The medical treatment of cardiogenic shock
por: Lescroart, Mickael, et al.
Publicado: (2023)

AT1 receptor-associated protein and septic shock-induced vascular hyporeactivity: another 'magic bullet' in the pipe?
por: Kimmoun, Antoine, et al.
Publicado: (2013)

Angiotensin II: a new approach for refractory shock management?
por: Kimmoun, Antoine, et al.
Publicado: (2014)

Cardiac Contractile Reserve Parameters Are Related to Prognosis in Septic Shock
por: Kimmoun, Antoine, et al.
Publicado: (2013)

Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock
por: Wei, Chaojie, et al.
Publicado: (2016)

Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside
por: Kimmoun, Antoine, et al.
Publicado: (2015)

Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
por: Levy, Bruno, et al.
Publicado: (2021)

Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014)

β-blockers in septic shock: are we there yet?
por: Cruz, Madalena Coutinho, et al.
Publicado: (2017)

Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: Experimental report and review of literature
por: Favier, Valentin, et al.
Publicado: (2022)

Time-Controlled Adaptive Ventilation Does Not Induce Hemodynamic Impairment in a Swine ARDS Model
por: Lescroart, Mickael, et al.
Publicado: (2022)

Methylene Blue Reduces Fluid Loading and Norepinephrine Requirements for Post-Resuscitation Syndrome in a Pig Model of Refractory Cardiac Arrest Resuscitated with Veno-Arterial ECMO
por: Pequignot, Benjamin, et al.
Publicado: (2022)

90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment
por: Fuchs, C, et al.
Publicado: (2015)

Erratum to: Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside
por: Kimmoun, Antoine, et al.
Publicado: (2017)

Bench-to-bedside review: Is there a place for epinephrine in septic shock?
por: Levy, Bruno
Publicado: (2005)

Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside
por: Lescroart, Mickaël, et al.
Publicado: (2022)

Evaluation of Cardiac Function Index as Measured by Transpulmonary Thermodilution as an Indicator of Left Ventricular Ejection Fraction in Cardiogenic Shock
por: Perny, Jessica, et al.
Publicado: (2014)

New conclusive data on human myocardial dysfunction induced by acidosis
por: Kimmoun, Antoine, et al.
Publicado: (2012)

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Beta Blockers as Salvage Treatment in Refractory Septic Shock Complicated With Dynamic Left Ventricular Outflow Tract Obstruction: A Rare Case Presentation
por: Pablo, Catalá-Ruiz, et al.
Publicado: (2021)

Outcome of patients with septic shock and high-dose vasopressor therapy
por: Auchet, Thomas, et al.
Publicado: (2017)

Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMO
por: Valentin, Simon, et al.
Publicado: (2023)

Predicting clinical outcome in patients undergoing VA-ECMO
por: Kimmoun, Antoine, et al.
Publicado: (2019)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

New Insights into the Fluid Management in Patients with Septic Shock
por: Moschopoulos, Charalampos D., et al.
Publicado: (2023)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
por: Cojocariu, Sabina Alexandra, et al.
Publicado: (2021)

Managing septic shock
por: Gerlach, Herwig, et al.
Publicado: (2010)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Terlipressin in septic shock: what do we know?
por: Liu, Zi-Meng, et al.
Publicado: (2020)

Vasoplegia treatments: the past, the present, and the future
por: Levy, Bruno, et al.
Publicado: (2018)

Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19
por: Kimmoun, Antoine, et al.
Publicado: (2020)

The Role of Complement System in Septic Shock
por: Charchaflieh, Jean, et al.
Publicado: (2012)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
por: Kamath, Shiwani, et al.
Publicado: (2023)

Topical beta‐blockers in dermatologic therapy
por: Filoni, Angela, et al.
Publicado: (2021)

What does high NT-proBNP mean in septic shock patients? A part of the puzzle
por: Roch, Antoine
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_9c04ic90lh0jvbge9grbgv69vj